The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events.
Asian journal of surgery（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined